Another possible mechanism worth mentioning that was not addressed in the current study is the potential of S-NACH interfering with antigen presentation or B cell function given the findings that the drug was efficient at reducing IgE production both in the acute and chronic models of asthma. This evidence concerns the gene IGHE and asthma.